toradol
PreclinicalSmall molecule
toradol is one of 60 small molecule programs targeting Renal Colic. It is currently in Preclinical.
2
Indications
10
Total Trials
0
Active Trials
59
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
66 competitors in Total Knee Arthroplasty
#DrugCompanyPhaseTrials
1Cyklokapron
JJ Molner
Approved
Naropin
FFresenius Kabi USA, LLC
Approved
Marcaine
IInnocoll
Approved
Decadron
AAspen Global Incorporated
Approved
Medrol
PfizerApproved
Carbocaine
PfizerApproved
Lexapro
AbbVieApproved
Journavx
Vertex PharmaceuticalsApproved
Duragesic
CCephalon
Approved
MS Contin
HHikma Pharmaceuticals LLC
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Spinal Fusion1 trial
5 more indications
Ankle Surgery1 trial
Renal Colic1 trial
An Analgesia Protocol for Acute Renal Colic in the Emergency Department
Completed·—·N/A·NCT00504283·45 enrolled
Total Knee Arthroplasty1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for toradol. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details